Koiti Inokuchi
Division of Hematology
Department of Internal Medicine
Nippon Medical School
1-1-5 Sendagi
Japan
Name/email consistency: high
- RCSD1-ABL1-positive B lymphoblastic leukemia is sensitive to dexamethasone and tyrosine kinase inhibitors and rapidly evolves clonally by chromosomal translocations. Inokuchi, K., Wakita, S., Hirakawa, T., Tamai, H., Yokose, N., Yamaguchi, H., Dan, K. Int. J. Hematol. (2011)
- Chronic myelogenous leukemia: from molecular biology to clinical aspects and novel targeted therapies. Inokuchi, K. J. Nippon. Med. Sch (2006)
- Myeloproliferative disease in transgenic mice expressing P230 Bcr/Abl: longer disease latency, thrombocytosis, and mild leukocytosis. Inokuchi, K., Dan, K., Takatori, M., Takahuji, H., Uchida, N., Inami, M., Miyake, K., Honda, H., Hirai, H., Shimada, T. Blood (2003)
- Loss of DCC gene expression is of prognostic importance in acute myelogenous leukemia. Inokuchi, K., Yamaguchi, H., Hanawa, H., Tanosaki, S., Nakamura, K., Tarusawa, M., Miyake, K., Shimada, T., Dan, K. Clin. Cancer Res. (2002)
- Establishment of a cell line with AML1-MTG8, TP53, and TP73 abnormalities from acute myelogenous leukemia. Inokuchi, K., Hamaguchi, H., Taniwaki, M., Yamaguchi, H., Tanosaki, S., Dan, K. Genes. Chromosomes. Cancer (2001)









